Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2006
11/08/2006CN1857740A Tumor model and method
11/08/2006CN1857739A Tumor model and method
11/08/2006CN1283320C Liver specificity CT contrast medium and its preparation method
11/07/2006US7132234 or drug targets; contacting a poxviral p28 polypeptide with a candidate agent, and determining an effect on ubiquitin ligase activity of the p28; ubiquitylating a substrate by combining an E1 polypeptide, an E2 polypeptide, ubiquitin and a poxvirus P28 protein; variola virus (smallpox) drug discovery
11/07/2006US7132096 Inhibiting enoyl reductase; altering pathway of fatty acid synthesis; screening
11/07/2006CA2130703C Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them
11/07/2006CA2091967C Monoclonal anti-ganglioside antibody, its preparation and use as a tumor therapeutic agent
11/02/2006WO2006116742A2 Fluorescent nanoparticles conjugated to antibodies via a peg linker
11/02/2006WO2006116721A1 Ex vivo gene expression in whole blood as a model of assessment of individual variation to dietary supplements
11/02/2006WO2006116538A2 Medical device with a marker
11/02/2006WO2006116403A2 Intracellular thermal ablation using nano-particle electron spin resonance heating
11/02/2006WO2006116083A2 The 1, 5-anhydroglucitol (1, 5-ag) assay and a1c/1. 5-ag assay combination for measuring blood glucose excursions in general and postprandial hyperglycemia in diabetic patients
11/02/2006WO2006116021A2 Mri technique based on electron spin resonance and endohedral contrast agent
11/02/2006WO2006115416A2 Liposomes
11/02/2006WO2006115155A1 Liposome-containing preparation and process for producing the same
11/02/2006WO2006114286A2 Production of albumin-fluorescein conjugates for use in intraoperative diagnosis
11/02/2006WO2006084257A3 Steady state perfusion methods
11/02/2006WO2006072948A3 Gastro-retentive diagnostic assemblies
11/02/2006WO2006039663A3 Methods for the administration of iloperidone
11/02/2006WO2004032711A3 Diagnosis and monitoring of inflammation, ischemia and appendicitis
11/02/2006US20060246085 Methods for manipulating satiety
11/02/2006US20060246039 Growth differentiation factor-7
11/02/2006US20060246006 CD39L3 and its role in diabetes
11/02/2006EP1716871A2 Diagnostic imaging contrast agents with extended blood retention
11/02/2006EP1716870A1 MRI contrast agents endowed with concentration independent responsiveness
11/02/2006EP1716426A1 Method for the hyperpolarisation of atomic nuclei and device for carrying out said method
11/02/2006EP1715897A2 High frequency ultrasound imaging using contrast agents
11/02/2006EP1715870A1 Inhibition of protein kinase c-related kinase (prk) as a treatment for cardiac hypertrophy and heart failure
11/02/2006EP1467761B1 Treatment of neovascular ophthalmic disease
11/02/2006EP1223925B1 Fatty acid derivative for the treatment of external secretion disorders
11/02/2006CA2606018A1 Nanoparticle conjugates
11/01/2006CN1856547A Fluorinated dyes or colorants and their uses
11/01/2006CN1854157A Antibodies to insulin-like growth factor i receptor
11/01/2006CN1854122A Blood pool agents for nuclear magnetic resonance diagnostics
11/01/2006CN1853732A Matrix metalloproteinase inhibitors as target component in diagnose agent
11/01/2006CN1853730A Modified cytokines for use in cancer therapy
10/2006
10/31/2006US7129222 Immunomodulatory formulations and methods for use thereof
10/31/2006US7129219 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group
10/31/2006US7128896 using carbocyanine dyes; photodynamic therapy; in vivo supplying to tumor
10/31/2006US7128895 Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability
10/31/2006US7128894 Contrast enhancing solution for use in confocal microscopy
10/31/2006US7128893 Used to target radionuclides to cells, such as a variety of tumor cell types, for use in diagnostic imaging; peptide derivatives of vitamins such as folate, riboflavin, thiamine, vitamin B12, and biotin chelated to a radionuclide
10/26/2006WO2006113237A2 Cd39l3 and its role in diabetes
10/26/2006WO2006112443A1 Novel method of using triacetin and auxiliary agent for ultrasonic diagnostic examination
10/26/2006WO2006076343A8 Mycobacteria expressing hiv-1 and malaria antigens
10/26/2006WO2002101008A3 Intracellular signaling molecules
10/26/2006US20060241466 Hollow microspheres with controlled fragility for medical use
10/26/2006US20060241170 Methods and formulations of taxanes
10/26/2006US20060240064 Medical implants and fibrosis-inducing agents
10/26/2006US20060240063 Medical implants and fibrosis-inducing agents
10/26/2006US20060240004 Methods for treating tweak-related conditions
10/26/2006US20060239926 Specific high-relaxivity compounds
10/26/2006US20060239925 Method of manufacturing pharmaceutical preparation containing liposomes
10/26/2006US20060239924 Carrier with a metal binding domain, a metal ion, and an active agent; e.g., polylysine with a polyoxyethylene side chain with a polyalkylenepolyaminepolyacetic acid bonded to a transition metal ion bonded to a protein or nucleotide; drug delivery
10/26/2006US20060239923 Gastrin releasing peptide compounds
10/26/2006US20060239922 Water-soluble fluoro-substituted cyanine dyes as reactive fluorescence labelling reagents
10/26/2006US20060239921 Real time vascular imaging during solid organ transplant
10/26/2006US20060239914 bombesin, derivatives and/or analogues capable of complexing metal ions, radionuclides or optical labels, for use in radiotherapy
10/26/2006US20060239913 Peptide conjugate for magnetic resonance imaging
10/26/2006US20060239912 Carrier molecules
10/26/2006DE102005019452A1 New 18-fluorine-substituted 3'-deoxythymidine derivatives, useful in positron emission tomography, particularly for detection of brain tumors
10/26/2006DE102005019104A1 New conjugate of fluorescent dye bonded directly to protein, useful for intraoperative representation of tumors, inflammation and lymph nodes
10/26/2006CA2604675A1 Diagnostic and therapeutic potential of immune globulin intravenous (igiv) products
10/25/2006EP1713935A1 Modulation of hsv infection
10/25/2006EP1713821A2 Primary central nervous system tumor specific behab isoforms
10/25/2006EP1713514A2 Drugs and gene carrier particles that rapidly move through mucous barriers
10/25/2006EP1713513A2 Cellular labeling for nuclear magnetic resonance techniques
10/25/2006EP1713512A2 Contrast agents for myocardial perfusion imaging
10/25/2006EP1713499A1 Methods and compounds for modulating triglyceride and vldl secretion
10/25/2006EP1713457A2 Novel drugs and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases
10/25/2006EP1558293A4 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
10/25/2006EP1534990B1 Automated dynamic pressure-responsive hyperpolarized gas dispensing systems, and associated methods and computer program products
10/25/2006EP1487334A4 Paramagnetic particles that provide improved relaxivity
10/25/2006EP1420880A4 Stabilization and terminal sterilization of phospholipid formulations
10/25/2006EP1135170B1 Radioconjugation of internalizing antibodies
10/25/2006EP1109901B1 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF
10/25/2006EP0977599B1 Contrast agents comprising an azeotropic mixture of two gases for ultrasound investigations
10/25/2006CN1852728A Host defense factor X (HDFX)
10/25/2006CN1281278C Gene-carrying micro-bublle of target transfergene, its preparation method and use
10/24/2006US7126004 Thiazoline acid derivatives
10/24/2006US7125965 an spiro(1-benzopyran-2,2'-indole) indicator coupled to a lanthanide-chelated DO3A macrocycle; conformational changes of the indicator affect the interaction of the bound lanthanide with water
10/24/2006US7125860 Cross-linked derivatives of hyaluronic acid
10/24/2006US7125683 Preparations for diagnosis extrapancreatic secretory function
10/24/2006US7125541 Administering targeting agent operatively attached to a therapeutic agent, and wherein the targeting agent recognizes and binds to a tumor-associated endothelial cell marker
10/24/2006CA2273549C Diagnostic agents for pancreatic exocrine function
10/24/2006CA2212744C Microcapsules of predetermined peptide(s) specificity(ies), their preparation and uses
10/19/2006WO2006110172A2 Steroid analogs and characterization and treatment methods
10/19/2006WO2005094327A9 Isolation of epithelial cells or their biochemical contents from excreta after in vivo isotopic labeling
10/19/2006US20060235312 Combination and method including a visual marker for determining compliance with a medication regimen
10/19/2006US20060235296 Contrast enhanced x-ray phase imaging
10/19/2006US20060235292 Magnetic resonance imaging method and compounds for use in the method
10/19/2006US20060235193 Biocompatible materials and probes
10/19/2006US20060234909 Compositions and methods for increasing drug efficiency
10/19/2006US20060234317 Method of screening
10/19/2006US20060233794 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
10/19/2006US20060233754 A kit containing a compound promoting delivery of exogenous genes to cells, e.g., 1-(5-chloro-2-hydroxyphenyl)-3-(3-pyridinyl)-1,3-propanedione; 1-Tetradecylarsonic acid; N1-(2-fluoro-9-acridinyl)-N3N3-dimethyl-1,3-propanediamine; and N4(bis(2-chloroethy)amino)benzylidene)1,3-thiazol-2-amine
10/19/2006US20060233713 Gadolinium particle-based MRI contrast agents
10/19/2006US20060233712 Magnetic nanoparticles
10/19/2006US20060233711 Method for treating conditions associated with fear memory
10/19/2006US20060233710 Prevention and treatment for GVHD